[Cardiomyopathy: progress in diagnosis and treatments. Topics: III. Diagnosis leading to selection of therapy: 2. Biomarker]

Nihon Naika Gakkai Zasshi. 2014 Feb 10;103(2):345-52. doi: 10.2169/naika.103.345.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Biomarkers / analysis
  • Cardiomyopathies / diagnosis*
  • Cardiomyopathies / metabolism
  • Cardiomyopathies / therapy*
  • Humans
  • Natriuretic Peptide, Brain / metabolism
  • Neurotransmitter Agents / metabolism
  • Prognosis
  • Risk Factors

Substances

  • Biomarkers
  • Neurotransmitter Agents
  • Natriuretic Peptide, Brain